ALCOHOL USE DISORDER: SCREENING IN PRIMARY CARE AND PHARMACOLOGICAL MAINTENANCE STRATEGIES
Abstract
Unhealthy alcohol use is often under-recognized in general medical care, but the transition from recognition to structured treatment remains inconsistent. Primary care is strategically positioned to identify risk patterns, distinguish screening from diagnosis, initiate brief interventions, assess withdrawal risk, and coordinate longitudinal treatment. This narrative review examines screening approaches applicable to primary care and pharmacological maintenance strategies for adults with alcohol use disorder. Searches were conducted in 2026 in PubMed/MEDLINE and in official sources from the World Health Organization, Brazilian Ministry of Health, U.S. Preventive Services Task Force, American Psychiatric Association, National Institute for Health and Care Excellence, and U.S. Department of Veterans Affairs/Department of Defense. Evidence supports brief instruments such as AUDIT-C or other abbreviated AUDIT formats as an initial step, followed by clinical assessment when screening is positive. For maintenance treatment, oral naltrexone and acamprosate have the most consistent evidence, although their clinical suitability differs according to treatment goals, opioid exposure, hepatic or renal function, and adherence. Disulfiram is better reserved for selected patients pursuing abstinence under close supervision, while topiramate and gabapentin are alternatives in specific circumstances. Effective primary care management depends on linking screening to diagnostic clarification, psychosocial care, individualized pharmacotherapy, follow-up, and timely referral when clinical complexity exceeds local capacity.